PATENT CLAIM ANALYSIS

Application Number: 15776043
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "230500"]

Abstract:
An injection solution can be used in a pharmaceutical dosage formulation. The injection solution includes an organic solvent, a copolymer, which is a poly(lactide-co-glycolide) dissolved in the organic solvent, and a pharmaceutical active ingredient, which is a non-nucleoside inhibitor of the HIV reverse transcriptase or of the HIV integrase, and which contains aromatic and heterocyclic aromatic or aromatic and heterocyclic aromatic and aliphatic heterocyclic groups, where a content of the pharmaceutical active ingredient is from about 8 to about 25% by weight of the copolymer solution.

Claim (Index 13):
A triple therapy method of treating a subject with an antiretroviral HIV treatment, the method comprising:\n injecting the injection solution according to  claim 1 , combined with daily oral fixed dose formulations of at least one nucleoside reverse transcriptase inhibitor or at least one further non-nucleoside reverse transcriptase inhibitor or both and optionally with a booster, which is a liver enzyme inhibitor \u2014  into a subject in need thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 93.0
- Lexical Diversity: 1.84906
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12709473', '12933757', '13640653', '14862875', '15231365']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.766354250560279
- 35 USC 102 Novelty (BERT): 0.4973444768323881
- Combined Prediction Score: 0.7394532731874899
- Mean Citation Score: 212.110914
- Max Citation Score: 219.36395
- Similarity Product: 155.20617496814432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test